Shareholding disclosure

ADDEX THERAPEUTICS LTD

Declared position

51%

Threshold

Crossed downwards

Timeline

Published

21.04.2022

Transaction

12.04.2022

Voting rights breakdown

Voting rights acquired42.04%

Voting rights sold51%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAM4D000B0

Beneficial owner

ADDEX THERAPEUTICS LTD

Declared address

ADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

50% threshold crossing on sale position.

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

ADDEX THERAPEUTICS LTD

Addex Therapeutics Ltd21.04.2022TAM4D000B0

Disclosure summary

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd on the disposal side, published by SIX Exchange Regulation on 21.04.2022, at 51% of voting rights. Notice category: Single shareholder.

Disclosed position

51%

Voting rights sold

Voting rights acquired42.04%

Voting rights sold51%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

ADDEX THERAPEUTICS LTD disclosed a holding in Addex Therapeutics Ltd, published on 21.04.2022.

Publication date21.04.2022

Transaction date12.04.2022

Issuing companyAddex Therapeutics Ltd

Beneficial ownerADDEX THERAPEUTICS LTD

Declared addressADDEX THERAPEUTICS LTD, 1228 PLAN-LES-OUATES

CategorySingle shareholder

Voting rights acquired42.04%

Voting rights sold51%

Below threshold0%

ExchangeXSWX

Notification IDTAM4D000B0

Commercial register

CHE-113.514.094

Registered

Zefix record

Conditions

50% threshold crossing on sale position.

Source: SIX Exchange Regulation · Publication date: 21.04.2022

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open